CA
CELG

CapWealth Advisors’s Celgene Corp CELG Stock Holding History

CapWealth Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-60
Closed -$5K – 449
2013
Q3 		$5K Hold
60
– – ﹤0.01% 373
2013
Q2 		$4K Buy
+60
New +$3.61K ﹤0.01% 370

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CapWealth Advisors's CELG Position: Q4 2013 in Review

CapWealth Advisors sold out of Celgene Corp (CELG) in Q4 2013, closing a stake of 60 shares — an estimated $5K sold.

CapWealth Advisors first reported a position in CELG in Q2 2013 and held it in 2 quarters. The position peaked at $5K in Q3 2013. 983 funds tracked by Wall St. Rank hold CELG as of Q4 2013.

  • CapWealth Advisors reported no remaining Celgene Corp position as of Q4 2013 after selling out during the quarter.
  • CapWealth Advisors sold 60 Celgene Corp shares in Q4 2013, an estimated $5K.
  • CapWealth Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 2 quarters.
  • CapWealth Advisors's Celgene Corp position peaked at $5K in Q3 2013.
  • 983 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2013.

Based on CapWealth Advisors's 13F filing for Q4 2013, filed 13 Feb 2014.